GSK3B and Alzheimer disease: Pathological CDC42 overactivation, as observed in AD patients, can induce f‐actin breakdown, synapse defects, and Tau hyperphosphorylation via recruitment of the Tau kinase GSK‐3β (Ying et al. 2022; Zhu et al. 2023).